Cite

HARVARD Citation

    Musella, A. et al. (n.d.). 'Prototypical' proinflammatory cytokine (IL-1) in multiple sclerosis: role in pathogenesis and therapeutic targeting. Expert opinion on therapeutic targets. pp. 37-46. [Online]. 
  
Back to record